Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Recombinant Human beta-Defensin 4 (rHuBD-4)

Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The α-defensins are distinguished from the β-defensins by the pairing of their three disulfide bonds. To date, four human β-defensins have been identified; BD-1, BD-2, BD-3 and BD-4. The β-defensin proteins are expressed as the C-terminal portion of precursors and are released by proteolytic cleavage of a signal sequence. β-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. β-defensins are 3-5 kDa peptides ranging in size from 33-47 amino acid residues. BD-4 is expressed in testis, stomach, uterus, neutrophils, thyroid, lung and kidney. In addition to its direct antimicrobial activities, BD-4 is chemoattractant towards human blood monocytes.

Product Specifications

Source

Escherichia coli.

Endotoxin

Less than 1EU/g of rHuBD-4 as determined by LAL method.

Purity

>98% by SDS-PAGE and HPLC analyses.

Bioactivity

Determined by its ability to chemoattract human monocytes using a concentration range of 0.1-100.0 ng/ml, corresponding to a Specific Activity of >1 x 104 IU/mg.

Form

Lyophilized from a 0.2m filtered concentrated solution in 20mM PB, pH 7.4, 130mM NaCl.

Molecular Weight

Approximately 6.0 KDa, a single non-glycosylated polypeptide chain containing 50 amino acids.

Storage Conditions

This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.

Notes

For research use only.

Applications Notes

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at < -20°C. Further dilutions should be made in appropriate buffered solutions.

Preservative

Lyophilized from a 0.2m filtered concentrated solution in 20mM PB, pH 7.4, 130mM NaCl.

AA Sequence

EFELDRICGY GTARCRKKCR SQEYRIGRCP NTYACCLRKW DESLLNRTKP

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Tenascin (T2H5), CF405S conjugate, 0.1mg/mL
BNC040392-100 1x 100 µL

Tenascin (T2H5), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Annexin A2 (ANXA2) (NM_001002858) Human Over-expression Lysate
LY400370 100 µg

Annexin A2 (ANXA2) (NM_001002858) Human Over-expression Lysate

Sign In for Pricing
View Details
Recombinant Rat JAM-B/CD322 Protein (Fc Tag)
PKSR030197 100 µg

Recombinant Rat JAM-B/CD322 Protein (Fc Tag)

Sign In for Pricing
View Details
TissueScan, Bladder Cancer cDNA Array I
BLRT301 5 Panels

TissueScan, Bladder Cancer cDNA Array I

Sign In for Pricing
View Details
trans-4-Hydroxy-L-proline
TRC-H952376-25G 25 g

trans-4-Hydroxy-L-proline

Sign In for Pricing
View Details
Human C11orf10 (TMEM258) activation kit by CRISPRa
GA100519 1 Kit

Human C11orf10 (TMEM258) activation kit by CRISPRa

Sign In for Pricing
View Details